Navigation Links
Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant
Date:12/15/2008

JEFFERSON, N.C., Dec. 15 /PRNewswire/ -- Inhalers used for delivering albuterol, a fast-acting bronchial dilator, currently use propellants such as ozone-depleting CFC's, which are banned by the FDA beginning December 31st, 2009, or replacement HFA's. Both propellants are also used as industrial refrigerants and eject the medicine, albuterol, at near-supersonic speeds.

The Next Safety device supplies medication in a stream of air by ejecting the medication from a microfluidic pump automatically as the patient breathes, solving three problems:

(1) Propellants are eliminated. Patients are no longer required to inhale refrigerants.

(2) The medicine is not ejected at high speeds, where it is deposited on the back of the throat and ingested. This is such a concern that certain manufacturers of the new HFA-based albuterol inhalers recommend that patients "rinse and spit" after each treatment.

(3) Patients do not need to time their inhalation to match the push of a button. This is particularly important when administering albuterol to children where the parent is pressing a button hoping the child will breath at the same time. Therefore, parents can never be certain of dosing, which is one reason why 25% of all emergency room visits in the US are related to asthma.

The other method used to dose albuterol is the nebulizer, a large compressor-driven device that essentially sprays droplets of albuterol while a child breathes from a mist for a 20 - 30 minute period. This treatment, invented in 1975, is cumbersome and often not available to an asthmatic when a fast-acting dose of albuterol is needed.

Phillip Weaver, the President of Next Safety and an inventor of the technology, explains: "The device uses a silicon microfluidic pump to eject droplets of an off-the-shelf FDA-approved solution of albuterol sulfate in water that are a predetermined size into an air stream created by a miniature blower to deliver the droplets at the same speed of the patient's inhalation and in the correct size range for bronchial delivery."

According to Dr. Tom Stearn, a pulmonologist and consultant for Next Safety, "The platform offers the ability to deliver not only albuterol in air, but also other medications for treating asthma, such as fluticasone propionate and salmeterol xinofoate, the components of Advair." Certain chemical patents for Advair expired in August 2008.

The device also provides an electronic output to PDA's so that, in the future, doctors can monitor the results of specific doses of medications in addition to patient compliance.

Advanced designs of the platform use measurements of exhaled nitric oxide (NO) together with peak respiratory flow, which when combined are a predictor of an asthma attack, to automatically adjust doses and provide alarms to physicians and parents.

    Photos:
   http://www.ereleases.com/pr/2008-NextSafety.jpg
   http://www.ereleases.com/pr/2008-NextSafety2.jpg


    Website:http://www.nextsafety.com

    Contact:

George Colvard, COO Next Safety, georgecolvard@nextsafety.com, 336-246-7700

Philip Weaver, President Next Safety, philipweaver@nextsafety.com, 336-246-7700

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Next Safety, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
2. Controversial New Pool & Spa Safety Act Will Create Public Pool Closures Nationwide
3. Nursing Data on Patient Safety in California Will Expand to Include Two Pacific Northwest States
4. FDA Panel Mulls Safety of Asthma Meds
5. Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety
6. Top Heart Programs Choose Safety of Medivances Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia
7. Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)
8. RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions
9. SafetyTies Keep Getting Safer: Newest Neckties Reduce the Spread of Germs and Stylishly Feature the Microbes They Fight
10. South Florida Dermatologists Win Over Golf Fans With Sun Safety Outreach at LPGA Playoffs
11. Talyst Moves Patient Safety and Inventory Control Beyond the Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: